Evidence map›Paper›PMID 14585990›Full record

ArticleMolecular and cellular biology2003

TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-kappaB.

Surinder M Soond, Jennifer L Terry, Jeff D Colbert, David W H Riches

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Ubiquitination and Metabolic Disease.Advances in experimental medicine and biology · 2024
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airways.American journal of respiratory cell and molecular biology · 2008
    Article
  9. Article
  10. Review
  11. A cancer-specific transcriptional signature in human neoplasia.The Journal of clinical investigation · 2005
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Surinder M SoondProgram in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, Neustadt Room D405, Denver, CO 80206, USA.
Jennifer L Terry
Jeff D Colbert
David W H Riches
National Jewish Health · USUniversity of Colorado Denver · US

Funding

Mechanisms of myofibroblast survival in fibrosisR01HL068628 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHES, DAVID W. · 2002 to 2011
$3.4M
TNFA RECEPTOR CD120A INDUCED SIGNALING IN MACROPHAGESR01HL055549 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHES, DAVID W. · 1996 to 2008
$3.2M
OSMOTIC REGULATION OF MACROPHAGES IN CYSTIC FIBROSISR01HL065326 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHES, DAVID W · 2000 to 2003
$1.2M
NHLBI NIH HHS HL 55549NHLBI NIH HHS HL 65326NHLBI NIH HHS HL 68628NHLBI NIH HHS R01 HL055549NHLBI NIH HHS R01 HL065326NHLBI NIH HHS R01 HL068628
6 · The paper itself

Abstract

We describe the cloning and characterization of tumor necrosis factor receptor (TNF-R)-associated ubiquitous scaffolding and signaling protein (TRUSS), a novel TNF-R1-interacting protein of 90.7 kDa. TRUSS mRNA was ubiquitously expressed in mouse tissues but was enriched in heart, liver, and testis. Co-immunoprecipitation experiments showed that TRUSS was constitutively associated with unligated TNF-R1 and that the complex was relatively insensitive to stimulation with TNF-alpha. Deletion mutagenesis of TNF-R1 indicated that TRUSS interacts with both the membrane-proximal region and the death domain of TNF-R1. In addition, the N-terminal region of TRUSS (residues 1 to 440) contains sequences that permit association with the cytoplasmic domain of TNF-R1. Transient overexpression of TRUSS activated NF-kappaB and increased NF-kappaB activation in response to ligation of TNF-R1. In contrast, a COOH-terminal-deletion mutant of TRUSS (TRUSS(1-723)) was found to inhibit NF-kappaB activation by TNF-alpha. Co-precipitation and co-immunoprecipitation assays revealed that TRUSS can interact with TRADD, TRAF2, and components of the IKK complex. These findings suggest that TRUSS may serve as a scaffolding protein that interacts with TNF-R1 signaling proteins and may link TNF-R1 to the activation of IKK.

Indexed as

Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsAmino Acid SequenceAnimalsAntigens, CDBinding SitesCell LineCloning, MolecularCOS CellsHumansMaleMiceMolecular Sequence DataNF-kappa BNIH 3T3 CellsProteinsReceptor-Interacting Protein Serine-Threonine KinasesAntigens, CDNF-kappa BProteinsReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Type IRecombinant ProteinsRIPK1 protein, humanRipk1 protein, mouseRNA, MessengerTNF Receptor-Associated Death Domain ProteinTNF Receptor-Associated Factor 1TNF Receptor-Associated Factor 2Tradd protein, mouseTrans-ActivatorsTRUSS protein, mouseTumor Necrosis Factor-alphaTumor Necrosis Factor Receptor-Associated Peptides and Proteins

Identifiers

PMID14585990
PMCPMC262424
OpenAlexW2008854365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.